Buy & Sell Oscar Health Inc (OSCR) – Oscar Health Inc Price Today
Aura AI Summary
Key Stats
- $8.79BMarket Cap
- HealthSector
- -19.99%3M Drawdown
- $4.41BEnterprise Value
- -Dividend Yield
- 35% Buy | 65% SellTrading Activity
- 6 daysTypical Hold Time
Oscar Health Inc (OSCR) is currently valued at a market capitalization of $8.79B, with an enterprise value of $4.41B. Over the past 52 weeks, Oscar Health Inc has traded between a low of $10.85 and a high of $29.14, highlighting its annual price range. Over the past three months, Oscar Health Inc has recorded a drawdown of -19.99%, reflecting recent price volatility. On average, investors hold Oscar Health Inc for approximately 6 days, indicating typical investor behavior on the platform.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Most Recent News
Scilex shares jump 18.79% on Dream Bowl Meme Coin listing news
Scilex Holding Company saw its shares rise 18.79% after announcing that its Dream Bowl Meme Coin tokens could start trading on Biconomy Exchange as early as June 23. The listing is expected to boost liquidity and expand distribution to eligible token...

Aditxt shares plunge nearly 34% after major shareholder buys millions of shares.
Aditxt Inc. shares dropped 33.94% in after-hours trading following a disclosure that major shareholder HRT Financial LP purchased over 4.2 million shares at $0.016 each. Despite this large purchase, the stock continues to face heavy selling pressure,...

Resolution Therapeutics advances Regenerative Macrophage Therapy with new in vivo lipid nanoparticle delivery program.
Resolution Therapeutics has signed agreements to access lipid nanoparticle (LNP) technology to develop its in vivo Regenerative Macrophage Therapy (RMT) for inflammatory and fibrotic diseases. This new program aims to complement its ongoing autologou...
